Francesca Zanderigo Selected Research

Francesca Zanderigo Research Topics

Disease

9	Major Depressive Disorder (Major Depressive Disorders) 03/2024 - 07/2010
3	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2017
3	Mood Disorders (Mood Disorder) 12/2022 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 12/2023 - 12/2018
2	Inflammation (Inflammations) 11/2022 - 12/2018
2	Arthritis (Polyarthritis) 12/2018 - 08/2018
2	Neoplasms (Cancer) 12/2018 - 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2021
1	Brain Neoplasms (Brain Tumor) 03/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Parkinson Disease 16 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2019
1	Wounds and Injuries (Trauma) 10/2019
1	Disease Progression 12/2018
1	Stroke (Strokes) 12/2018
1	Headache (Headaches) 08/2018
1	Mania (Manias) 01/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Pain (Aches) 01/2017
1	Cognitive Dysfunction 01/2017
1	Dementia (Dementias) 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Mental Disorders (Mental Disorder) 07/2009

Drug/Important Bio-Agent (IBA)

7	5-HT1A Serotonin ReceptorIBA 03/2024 - 11/2013
4	Antidepressive Agents (Antidepressants)IBA 03/2024 - 01/2018
4	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 07/2010
2	Apolipoprotein E4IBA 12/2023 - 11/2022
2	Arachidonic Acid (Vitamin F)IBA 11/2022 - 01/2018
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022 - 10/2019
2	EnzymesIBA 12/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 01/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022
1	Topoisomerase InhibitorsIBA 03/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 03/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	LigandsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	N,N,N-triethylhomocholineIBA 10/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	Harmine (Telepathine)IBA 01/2018
1	EicosanoidsIBA 01/2018
1	AutoreceptorsIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Monoamine Oxidase (MAO)IBA 01/2018
1	Glycogen Synthase Kinase 3IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Escitalopram FDA Link 11/2013
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 11/2013
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2009

Therapy/Procedure

1	Therapeutics 03/2021